{"database": "lobbying", "table": "lobbying_activities", "rows": [[3237377, "4b3f358f-b58d-4b43-8fbe-522fe90c2fc8", "Q3", "THE PETRIZZO GROUP, INC.", 305932, "OMEROS CORPORATION", 2024, "third_quarter", "MED", "Development and execution of initiatives involving multiple Omeros pipeline targets before the U.S. Government, including funding collaborations associated with COVID, Cancer, and addition within the Department of HHS, NIH, BARDA, and the White House. FDA Rare Disease Center of Excellence", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 75000, null, 0, 0, "2024-10-14T19:25:01-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3237377"], "units": {}, "query_ms": 19.468393991701305, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}